These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 18424191)
1. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191 [TBL] [Abstract][Full Text] [Related]
2. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Nemeroff CB; Thase ME; J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158 [TBL] [Abstract][Full Text] [Related]
4. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085 [TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Bose A; Korotzer A; Gommoll C; Li D Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245 [TBL] [Abstract][Full Text] [Related]
7. A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. March JS; Entusah AR; Rynn M; Albano AM; Tourian KA Biol Psychiatry; 2007 Nov; 62(10):1149-54. PubMed ID: 17553467 [TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug. Kiliç S; Ergin H; Baydinç YC Int J Androl; 2005 Feb; 28(1):47-52. PubMed ID: 15679621 [TBL] [Abstract][Full Text] [Related]
10. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089 [TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189 [TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia. Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843 [TBL] [Abstract][Full Text] [Related]
13. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Nicolini H; Bakish D; Duenas H; Spann M; Erickson J; Hallberg C; Ball S; Sagman D; Russell JM Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261 [TBL] [Abstract][Full Text] [Related]
14. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105 [TBL] [Abstract][Full Text] [Related]
15. A single-blind placebo run-in study of venlafaxine XR for activity-limiting osteoarthritis pain. Sullivan M; Bentley S; Fan MY; Gardner G Pain Med; 2009; 10(5):806-12. PubMed ID: 19496959 [TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. Baldomero EB; Ubago JG; Cercós CL; Ruiloba JV; Calvo CG; López RP Depress Anxiety; 2005; 22(2):68-76. PubMed ID: 16094658 [TBL] [Abstract][Full Text] [Related]
17. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study. Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133 [TBL] [Abstract][Full Text] [Related]
18. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910 [TBL] [Abstract][Full Text] [Related]
19. Venlafaxine in social phobia. Kelsey JE Psychopharmacol Bull; 1995; 31(4):767-71. PubMed ID: 8851651 [TBL] [Abstract][Full Text] [Related]